AN OVERVIEW OF ADJUVANT THERAPY FOR COLORECTAL-CANCER

被引:47
作者
HALLER, DG
机构
关键词
ADJUVANT THERAPY; COLON CANCER; RECTAL CANCER;
D O I
10.1016/0959-8049(95)00258-K
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adjuvant therapy of colorectal cancer is one of the most active areas of clinical oncology research. Although the data for the benefits from early trials of adjuvant therapy were inconclusive, these trials suffered from inadequate sample sizes, poor staging, potentially suboptimal treatment regimens and ill-defined prognostic subgroups. More recently, larger trials of higher scientific quality have demonstrated that regimens of fluorouracil plus levamisole in stage III colon cancer and fluorouracil with postoperative radiation in stages II and III rectal cancer can reduce mortality. Such regimens have now become standard practice in settings in which treatment is believed to be both efficacious and tolerable, and when the overall impact of therapy is considered to be clinically relevant. More recent advances in adjuvant treatment of colorectal cancer further support the role of fluorouracil-based regimens. Peri-operative portal vein infusions of fluorouracil demonstrate improved relapse-free and overall survival, and infusional fluorouracil administered with radiation for rectal primaries appears superior to less intensive bolus fluorouracil regimens. Completed trials of fluorouracil plus leucovorin combinations are awaiting maturation, with expectations for superior adjuvant activity based on demonstrated improved response rates for biochemically modulated fluorouracil in advanced metastatic colorectal cancer. New systemic agents are also entering large-scale adjuvant trials, including monoclonal antibody 17-1a, given alone and in conjunction with standard fluorouracil regimens. Additional cytotoxic drugs, including CPT-11 and Tomudex, offer new opportunities for alternative adjuvant regimens for the large, heterogeneous population of patients with resected colorectal cancer.
引用
收藏
页码:1255 / 1263
页数:9
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for the perineural invasion of colorectal cancer
    Suzuki, Toshiaki
    Suwa, Katsuhito
    Ogawa, Masaichi
    Eto, Ken
    Kawahara, Hidejiro
    Fujita, Tetsuji
    Ikegami, Masahiro
    Yanaga, Katsuhiko
    [J]. JOURNAL OF SURGICAL RESEARCH, 2015, 199 (01) : 84 - 89
  • [32] Efficacy of Surgery and Adjuvant Therapy in Older Patients With Colorectal Cancer A STROBE-compliant article
    Yang, Lie
    Ma, Qin
    Yu, Yong-Yang
    Wang, Cun
    Meng, Wen-Jian
    Adell, Gunnar
    Albertsson, Maria
    Arbman, Gunnar
    Jarlsfelt, Ingvar
    Peng, Zhi-Hai
    Li, Yuan
    Zhou, Zong-Guang
    Sun, Xiao-Feng
    [J]. MEDICINE, 2014, 93 (28) : e266
  • [33] Adjuvant therapy of colorectal cancer From coffee to acetylsalicylic acid to chemotherapy
    Kraeft, A-L
    Reinacher-Schick, A.
    Folprecht, G.
    [J]. GASTROENTEROLOGE, 2020, 15 (04): : 290 - 299
  • [34] Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer
    Wu, Chih-chien
    Su, Chien-chou
    Chen, Yu-hsun
    Hsu, Chao-wen
    Chang, Yu-ching
    Su, Yi-chia
    [J]. ANTICANCER RESEARCH, 2024, 44 (04) : 1619 - 1628
  • [35] Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
    Dodaro, Concetta Anna
    Calogero, Armando
    Tammaro, Vincenzo
    Pellegrino, Tommaso
    Lionetti, Ruggero
    Campanile, Silvia
    Menkulazi, Marsela
    Ciccozzi, Massimo
    Iannicelli, Anna Maria
    Giallauria, Francesco
    Sagnelli, Caterina
    [J]. OPEN MEDICINE, 2019, 14 (01): : 607 - 612
  • [36] Dietary fiber as a wide pillar of colorectal cancer prevention and adjuvant therapy
    de Freitas Pedrosa, Lucas
    Fabi, Joao Paulo
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2024, 64 (18) : 6177 - 6197
  • [37] Adjuvant treatment of colorectal cancer
    Segura, Carine
    Afchain, Pauline
    De Gramont, Aimery
    Andre, Thierry
    [J]. BULLETIN DU CANCER, 2006, 93 (07) : 683 - 690
  • [38] REGIONAL ADJUVANT THERAPIES FOR LIVER METASTASES IN COLORECTAL-CANCER - REQUIREMENTS FOR CLINICAL-TRIALS FROM THE STATISTICIANS VIEW
    MULLER, HH
    SCHAFER, H
    [J]. ZENTRALBLATT FUR CHIRURGIE, 1995, 120 (10): : 755 - 759
  • [39] COLONIC FERMENTATION AND MARKERS OF COLORECTAL-CANCER RISK
    KASHTAN, H
    STERN, HS
    JENKINS, DJA
    JENKINS, AL
    THOMPSON, LU
    HAY, K
    MARCON, N
    MINKIN, S
    BRUCE, WR
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (03) : 723 - 728
  • [40] DIET, ABERRANT CRYPT FOCI AND COLORECTAL-CANCER
    BRUCE, WR
    ARCHER, MC
    CORPET, DE
    MEDLINE, A
    MINKIN, S
    STAMP, D
    YIN, Y
    ZHANG, XM
    [J]. MUTATION RESEARCH, 1993, 290 (01): : 111 - 118